Udenafil

Source: Wikipedia, the free encyclopedia.
Udenafil
Clinical data
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • US: Not approved
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding93,9%
MetabolismLiver (mainly CYP3A4)
Elimination half-life7.3–12.1 hours
ExcretionBiliary
Identifiers
  • 3-(1-Methyl-7-oxo-3-propyl-4,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide
JSmol)
  • O=C2\N=C(/Nc1c(nn(c12)C)CCC)c3cc(ccc3OCCC)S(=O)(=O)NCCC4N(C)CCC4
  • InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32) checkY
  • Key:IYFNEFQTYQPVOC-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

The drug udenafil is marketed under the trade name Zydena. It is within the

U.S. Food and Drug Administration
.

References

  1. ^ Zydena (udenafil) product-information page. Dong-A Pharmaceutical. Retrieved on April 13, 2009.
  2. PMID 23554845
    .
  3. ^ "Zydena". Drugs.com.
genito-urinary system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Udenafil&oldid=1156287159"